Revenue | ₹2,193.37Cr |
Net Profits | ₹-136.19Cr |
Net Profit Margins | -6.21% |
Piramal Pharma Ltd’s revenue fell -1.79% since last year same period to ₹2,193.37Cr in the Q3 2025-2026. On a quarterly growth basis, Piramal Pharma Ltd has generated 3.26% jump in its revenue since last 3-months.
Piramal Pharma Ltd’s net profit fell -3800.82% since last year same period to ₹-136.19Cr in the Q3 2025-2026. On a quarterly growth basis, Piramal Pharma Ltd has generated -37.26% fall in its net profits since last 3-months.
Piramal Pharma Ltd’s net profit margin fell -3868.36% since last year same period to -6.21% in the Q3 2025-2026. On a quarterly growth basis, Piramal Pharma Ltd has generated -32.93% fall in its net profit margins since last 3-months.
The revenue for Piramal Pharma Ltd in the Q3 results 2025 was ₹2,193.37Cr.
The net profit for Piramal Pharma Ltd in the Q3 results 2025 was ₹-136.19Cr.
The net profit margin for Piramal Pharma Ltd in the Q3 results 2025 was -6.21%.
The revenue for Piramal Pharma Ltd in the Q3 results 2024 was ₹2,233.40Cr.
The net profit for Piramal Pharma Ltd in the Q3 results 2024 was ₹3.68Cr.
The net profit margin for Piramal Pharma Ltd in the Q3 results 2024 was 0.16%.